Scientists are one step closer to achieving gender parity, at least as far as birth control is concerned. While there are currently several contraceptive options targeted at women, there are only two for men – condoms and vasectomies.
The good news is that there are various reversible male birth control prototypes currently undergoing clinical trials. And the latest, a male oral contraceptive called dimethandrolone undecanoate (DMAU), appears to be safe and effective when taken daily for a month. The results of a recent study were presented by researchers at ENDO 2018, the Endocrine Society’s 100th annual meeting in Chicago, on Sunday.
“These promising results are unprecedented in the development of a prototype male pill,” Stephanie Page, professor of medicine at the University of Washington, said in a statement.